Business Wire

CTC Global Launches GridVista System and Strategic Partnership with Google Cloud and Tapestry to Transform Grid Intelligence

17.2.2026 12:00:00 CET | Business Wire | Press Release

Share

CTC Global, the world’s leading developer and manufacturer of high-capacity advanced conductors, today announced the launch of the GridVista System. The GridVista System provides utilities with real-time, high-resolution data to optimize grid capacity, prevent outages, reduce wildfire risk, and lower operational costs.

With the launch of the GridVista System, CTC is also announcing a deepening of its strategic partnership with Google Cloud and Tapestry—Alphabet’s moonshot for the electric grid. GridVista System’s unprecedented line awareness, paired with Google Cloud and Tapestry’s AI-powered tools, will transform line data into actionable intelligence for the grid.

The GridVista System redefines transmission line intelligence by utilizing optical fibers embedded directly within CTC Global’s ACCC Conductor. Unlike legacy technology that relies on external sensors to estimate line conditions, GridVista provides direct visibility into strain, temperature, and vibration across the entire length of a line. This allows utilities to identify "hidden" capacity in real-time, pinpoint precise fault locations to prevent wildfires, and shift from reactive maintenance to predictive, data-driven solutions.

“Real-time visibility into transmission lines is a gamechanger for utilities seeking to improve performance, lower operating risk and reduce costs,” said J.D. Sitton, CEO of CTC Global. “This new technology addresses critical utility pain points and represents truly next generation capabilities. CTC’s innovation and partnership with Google Cloud and Tapestry are ushering in a new era of grid intelligence.”

High-resolution hardware intelligence

Line intelligence from embedded optical fibers is shared continuously to the GridVista platform, where advanced analytics are applied to unlock new capacity, relieve congestion, and detect critical events.

By turning transmission lines from static infrastructure into intelligent network assets, the GridVista System will reduce the decade-long wait and massive capital costs associated with building new infrastructure, and these savings can be passed on to ratepayers.

“The GridVista System is an engineering breakthrough,” said Kevin Corbalis, chief technology officer of CTC Global. “Its insights will deliver value to multiple functions across the utility—engineering, operations, asset management, planning—to reduce risk and improve performance.”

AI-driven insights with Google Cloud

The GridVista Systemruns on Google Cloud’s high-performance infrastructure and is augmented by an advanced suite of Google Cloud technologies—Vertex AI, BigQuery data warehousing, Earth Engine and Google Maps imagery analytics, and WeatherNext environmental forecasting—to transform data into actionable insights. This intelligence allows operators to identify hidden capacity and optimize existing assets, enabling the delivery of affordable, reliable power to meet the record demands of electrification.

“To build infrastructure at the scale required for the future, we don't just need power; we need the transmission capacity to transport it,” said Raiford Smith, global director, Power and Energy, Google Cloud. “Our partnership with CTC Global is about getting more out of the grid we already have. By using AI to dynamically assess line conditions, we can help utilities bypass the years of delay and high capital costs, delivering affordable and reliable power faster.”

AI-enhanced planning with Tapestry

Tapestry will integrate high-fidelity data from GridVista into its comprehensive, virtualized grid model. By combining these operating insights with Tapestry’s AI-enabled tools, grid operators and project developers can run sophisticated simulations of line conditions. This precision allows for better planning and operating decisions, enabling partners to meet load growth by finding and harnessing the existing grid’s untapped potential.

“GridVista offers a new way to monitor and understand grid dynamics,” said Page Crahan, General Manager of Tapestry. “Bringing CTC Global’s advanced technology into the planning process will accelerate speed-to-power by revealing efficient, fast and affordable paths to expand capacity. It’s a critical step forward in creating a more resilient and reliable grid.”

To learn more about the GridVista™ System or to contact CTC Global, please visit www.ctcglobal.com/.

About CTC Global:

CTC Global is accelerating access to energy as the world’s leading manufacturer of high-capacity Advanced Conductors.

For over two decades, CTC Global has helped communities meet their energy needs and manage the risks associated with legacy transmission infrastructure. Today, over 300 utilities and industrial customers in over 65 countries and 30 U.S. states trust CTC to safely and quickly deploy solutions that add the greatest amount of electricity at the lowest capital cost.

Headquartered in Irvine, California, over half of CTC Global’s manufacturing capacity is U.S.-based. Its global operations are supported by five manufacturing facilities and an extensive network of partners around the world.

CTC Global’s Advanced Conductor is the most responsible and innovative solution to double capacity and improve reliability at scale. For more information, visit www.ctcglobal.com/.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260217383048/en/

Contacts

CTC Global
Anne McDowell
+1 (949) 428-8500
amcdowell@ctcglobal.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye